Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Merit Medical Systems ( (MMSI) ) has shared an update.
On May 14, 2025, Merit Medical Systems, Inc. held its Annual Meeting of Shareholders where shareholders voted on key proposals including the election of four directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent public accounting firm for 2025. All proposals were approved, indicating shareholder support for the company’s leadership and strategic direction.
The most recent analyst rating on (MMSI) stock is a Buy with a $93.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
Merit Medical Systems receives an overall score of 70, reflecting strong financial performance and positive earnings call insights. However, the high P/E ratio and technical resistance suggest cautious optimism. The company’s robust revenue growth and improved margins are key strengths, while managing leverage and tariff impacts will be crucial for future performance.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc. operates in the medical device industry, focusing on the development and manufacturing of disposable medical devices used in interventional, diagnostic, and therapeutic procedures, with a market focus on improving patient care and outcomes.
Average Trading Volume: 787,076
Technical Sentiment Signal: Buy
Current Market Cap: $5.84B
For detailed information about MMSI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue